Alice Turner

Professor & Consultant Respiratory Med, @PSRC_Midlands director. @NRAPaudit #QI lead. @AlphaFriend board member. Clinical & research #AATD #COPD.

[Alice Turner @AlphaCopdDoc]

Trip up north to learn with @NIHRresearch https://t.co/IuKY766M8E about maternity workforce, general medical training evaluation, neighbourhood working and more, on a campus built on the site of an old brewery

[Rohit Loomba @DrLoomba]

Great collaborative effort @AmerGastroAssn @AASLDPresident @EASLnews Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (AATD-LD) https://t.co/El4ZmhllUm

[National Respiratory Audit Programme @NRAPaudit]

📢One week left to apply for @NRAPaudit healthcare improvement clinical fellow. @ARNS_UK @BTSrespiratory @PRaccreditation
For further information and how to apply visit: https://t.co/RMNB6qE5J7

[PeerVoice @PeerVoice]

Missed our recent #AATD live event from Amsterdam? Watch the onDemand video to get insights on proactive screening, cross-specialty collaboration, and the current treatment landscape.
#PeerVoice #meded #AATD #pulmonology #hepatology
https://t.co/VPSE5Smbt5

[Alpha-1 Foundation @AlphaFriend]

The A1F team kicked off #Alpha1Awareness Month and the A1F Virtual Walk 2025 together at our Coral Gables office! The energy is high and we are ready for a month of awareness, advocacy, and community. Join us and be part of the movement: https://t.co/K6ZnxIx5nV

[West Midlands Physicians Association @WMPA_UK]

Here’s a reminder of the #WMPAMatMed programme happening at UHCW next month

Features talks on chest pain, headache and endocrine emergencies, plus research abstracts, case reports and posters in adult general internal medicine

Register here: https://t.co/cebyEdKryI

[Alice Turner @AlphaCopdDoc]

Great day with @NIHRPSRCs discussing safety equity. Loved the live graphics summarising talks (@PSRC_Midlands highlights 👇🏻) and the summary of maternal care pathway through an equity lens

[ATS Blue Journal @ATSBlueEditor]

Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease

PM2.5 and its constituents are associated with differential DNA methylation in the blood of patients with fibrotic ILD
@atscommunity

🔗 https://t.co/08LyOFDFSi

[Alice Turner @AlphaCopdDoc]

Genetic risk factors for disease susceptibility differ from those for progression/survival https://t.co/X0k6HLSjX9

[Alice Turner @AlphaCopdDoc]

Great talk on microplastics & lung health #ERSCongress2025 Key messages - more ingestion from air than gut, thus most deposition in the lung. Links to #COPD & ILD. The type of plastic matters

[Alice Turner @AlphaCopdDoc]

Methods to prevent respiratory disease and it's impacts, from #airquality interventions, case finding, lifestyle & more - summarised by @WHO in this report focussed on Europe #ERSCongress2025 https://t.co/rFqXmTBMnj

[Alice Turner @AlphaCopdDoc]

Shifting thinking toward prevention as the most cost-effective strategy in #copd Sounds sensible but not easy in many health systems #ERSCongress2025

[Alice Turner @AlphaCopdDoc]

Dupilumab for ABPA - signals for FEV1, possibly exacerbations, & QOL #ERSCongress2025

[NIHR Yorkshire and Humber PSRC @YHPSRC]

Join us for our next SafetyNet webinar: Understanding and measuring emergency doctors’ tolerance of clinical uncertainty on Wednesday 12 November

🔗Book your place: https://t.co/7Sg8pnFZp1...

@drwilliamlea @NIHRPSRCs
#emergencymedicine

[Alice Turner @AlphaCopdDoc]

ALIENTO study of Astegolimab, targeting IL33 in #COPD. Marginal effect on AECOPD, direction same as (negative) ARNASA study. Maybe too broad/late population? #ERSCongress2025

[Alice Turner @AlphaCopdDoc]

Started #ERSCongress2025 with an excellent NTM session. Take homes: many new routes to Rx, CFTR & GM-CSF clinical data promising. BACES score aids prognostication

[Fidel Rubagumya , MD, MMed, MPH @Rubagumyaf]

"We" need clinical trials & translational research, but the urgent gap is in health services & implementation science. We know much of what works; the challenge is delivering it equitably, affordably, and sustainably. Research must meet reality.

[James D Chalmers @ProfJDChalmers]

Treatable traits!
New! We compare inflammation, microbiome, rheology and mucins in asthma, COPD, bronchiectasis, CF and controls. Huge overlap in biology but clear neutrophilic and T2 endotypes in all diseases!
Endotypes>disease labels
@accpchest
https://t.co/61KzACwcGt

[CHEST® Journal @journal_CHEST]

Original research shows that preserved ratio impaired spirometry (PRISm) was associated with transition into airway obstruction corresponding to #COPD within one decade.

Read more in the August issue of the journal CHEST®: https://t.co/gcDSUxZShA
#MedEd #JournalCHEST

[Getting It Right First Time (GIRFT) @NHSGIRFT]

🚑 Maximising Ambulance Referrals into virtual wards via Single Point of Access (SPOA).

Dr Shelagh O’Riordan will be in conversation with ambulance & A&E colleagues exploring streamlining ambulance referrals into virtual care.

📅 Register: https://t.co/ql9SwTZaED
@jupiterhouse1